Asymmetric dimethylarginine in psychiatric disorders

Braun, Daniel and Schlossmann, Jens and Haen, Ekkehard (2021) Asymmetric dimethylarginine in psychiatric disorders. PSYCHIATRY RESEARCH, 300: 113901. ISSN 0165-1781, 1872-7123

Full text not available from this repository. (Request a copy)

Abstract

Serum concentrations of asymmetric dimethylarginine (ADMA) in patients with schizophrenia, schizoaffective disorder, bipolar disorder, and depression were determined and compared to serum concentrations in healthy individuals. In all psychiatric diseases investigated, the ADMA concentration was elevated compared to the control group. Patients with recurrent depressive disorder had higher ADMA levels than patients with only one depressive episode. No differences between women and men were found. The elevated ADMA levels suggest that ADMA is involved in the pathophysiology of psychiatric diseases.

Item Type: Article
Uncontrolled Keywords: NITRIC-OXIDE; SYMMETRIC DIMETHYLARGININE; REFERENCE VALUES; PLASMA; ADMA; SCHIZOPHRENIA; ARGININE; INHIBITOR; Depression; Schizoaffective disorder; Schizophrenia
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Chemistry and Pharmacy > Institute of Pharmacy > Pharmacology and Toxicology (Prof. Schlossmann, formerly Prof. Seifert)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 28 Jul 2022 10:02
Last Modified: 28 Jul 2022 10:02
URI: https://pred.uni-regensburg.de/id/eprint/46171

Actions (login required)

View Item View Item